Abstract

Sustainability, affordability, and equity of corporate drug donations: the case of Malarone

Shretta R, Brugha R, Robb A, Snow RW
Lancet. 2000;355

Permenent descriptor
https://doi.org/10.1016/S0140-6736(00)02251-0


No abstract available